Identifying genetic variants regulating MGMT gene expression- A study in monozygotic Danish twins

Identifying genetic factors affecting the regulation of the O-6-Methylguanine-DNA Methyltransferase (MGMT) gene and estimating the genetic contribution of the MGMT gene through within-pair correlation in monozygotic twin pairs is of particular importance in various types of cancer such as glioblastoma. We used gene expression data in whole blood from 448 monozygotic twins from the Middle Age Danish Twins (MADT) study to investigate genetic regulation of the MGMT gene by performing a genome-wide association study (GWAS) of the variation in MGMT expression. Additionally, we estimated within-pair dependence measures of the expression values looking for the genetic influence of significant identified genes. We identified 243 single nucleotide polymorphisms (SNPs) significantly (p < 5e-8) associated with expression of MGMT , all located on chromosome 10 near the MGMT gene. Of the 243 SNPs, 7 are novel cis-eQTLs. By further looking into the suggestively significant SNPs (increasing cutoff to p = 1e-6), we identified 11 suggestive trans-eQTLs located on chromosome 17. These variants were in or proximal to a total of seven genes, which may regulate MGMT expression. The within-pair correlation of the expression of MGMT , TRIM37 , and SEPT4 provided the upper bound genetic influence of these genes. Overall, identifying cis-or trans-acting genetic variations regulating the MGMT gene can pave the way for a better understanding of the MGMT gene function and ultimately in understanding the patient's sensitivity to therapeutic alkylating agents.

Automated summary

By performing a genome-wide association study on gene expression data from Danish twin pairs, 243 single nucleotide polymorphisms (SNPs) significantly associated with expression of the MGMT gene were identified, including 7 novel cis-eQTLs and 11 suggestive trans-eQTLs. These variations may regulate the function of the MGMT gene and the patient's sensitivity to therapeutic alkylating agents.